Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Assessing Zero Based Budgeting for individuals highlights benefits like clarity and control, alongside potential rigidity. This overview helps you decide thoughtfully.
28,655 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Pharmaceutical tariffs could quietly raise out-of-pocket drug costs and slow medical innovation. This guide explains ...
Imagine a single, low-cost index fund doing the heavy lifting for decades. This guide shows how to turn that idea int...
Nebius Group launches a $4 billion convertible-note round to accelerate a 1.2 GW AI data center project, backed by Nv...
When insiders sell, investors watch closely. This article unpacks a recent move at Laureate Education and translates ...
Lightstone opens access to 25,000+ multifamily units for accredited investors as rents rise in tight markets. The mov...
A wave of crypto venues is turning macro data and oil into around-the-clock trading products. Perpetual futures and p...
Brookfield Corporation just bought back a substantial amount of its own stock. The move raises questions about whethe...
A director quietly sold a notable stake in American Superconductor, prompting questions about what it signals for inv...
As AI accelerates, tech’s demand uninterrupted power is forcing investors to rethink NextEra Energy’s renewables-led ...
On the nation’s 250th birthday, economists and market experts outline ten reasons why America’s economy looks poised ...
The Supreme Court will hear a Boulder County climate-liability case against major oil producers, a move that could re...